The six patients with a PIK3CA mutation detected in their archival tumour had the corresponding PIK3CA mutation detected in their pre-treatment plasma ctDNA (at 920–31,300 copies/mL plasma) and in all on-treatment ctDNA samples (Table S1). This evidence concerns the gene PIK3CA and neoplasm.